Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)

SHA:600381 Revenue

Qinghai Spring Medicinal Resources Technology had revenue of 63.36M CNY in the quarter ending September 30, 2026, a decrease of -27.72%. This brings the company's total for the last twelve months to 253.35M, down -11.03% year-over-year. In the year 2025, Qinghai Spring Medicinal Resources Technology had annual revenue of 343.42M with 27.07% growth. That makes Qinghai Spring Medicinal Resources Technology the 29,865th largest company in the world by revenue and 4,941st in China.

• Revenue (ttm): 253.35M
• Revenue Growth: -11.03%
• P/S Ratio: 8.79
• Revenue / Employee: 1.89M
• Employees: 134
• Market Cap: 2.23B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Big Health Business 223.44M 54.3%
• Fast Selling Drinks 173.52M 42.2%
• Advertising Agency 14.26M 3.5%

By Geography

Chart

• East China 121.68M 35.9%
• Southwest 88.29M 26.0%
• Northwest 75.12M 22.2%
• South China 30.89M 9.1%
• North China 18.42M 5.4%
• Overseas 1.70M 0.5%
• Hong Kong, Macao and Taiwan 1.65M 0.5%
• Central China 1.29M 0.4%

Fiscal year ended Dec 31, 2025 See the full SHA:600381 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	343.42M	73.16M	27.07%
Dec 31, 2024	270.26M	56.39M	26.36%
Dec 31, 2023	213.88M	53.70M	33.52%
Dec 31, 2022	160.18M	32.41M	25.37%
Dec 31, 2021	127.76M	3.50M	2.81%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error